Metabolic Profiling of CHO Cells during the Production of Biotherapeutics

As indicated by an ever-increasing number of FDA approvals, biotherapeutics constitute powerful tools for the treatment of various diseases, with monoclonal antibodies (mAbs) accounting for more than 50% of newly approved drugs between 2014 and 2018 (Walsh, 2018). The pharmaceutical industry has mad...

Descripción completa

Detalles Bibliográficos
Autores principales: Coulet, Mathilde, Kepp, Oliver, Kroemer, Guido, Basmaciogullari, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221972/
https://www.ncbi.nlm.nih.gov/pubmed/35741058
http://dx.doi.org/10.3390/cells11121929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221972/
https://www.ncbi.nlm.nih.gov/pubmed/35741058
http://dx.doi.org/10.3390/cells11121929

Ejemplares similares